Analysis of curative effect of adjuvant therapy with bronchoalveolar lavage on COPD patients complicated with pneumonia

Abstract

Clinical effect of adjuvant therapy with bronchoalveolar lavage on chronic obstructive pulmonary disease (COPD) patients complicated with pneumonia and its influence on the expression levels of inflammatory factors were studied. One hundred and twenty mild-moderate COPD patients complicated with pneumonia treated in the Department of Respiratory Medicine, The Sixth People's Hospital of Nantong from February 2016 to February 2017 were selected and randomly divided into three groups: One-time lavage group (n=40), two-time lavage group (n=40) and control group (n=40). Fasting peripheral blood was collected from all the patients in the morning. The lung function and blood gas analyses, and the detection of peripheral white blood cells (WBC), procalcitonin (PCT) and C-reactive protein (CRP) were performed. Moreover, the messenger RNA (mRNA) levels of interleukin-6 (IL-6), IL-8, tumor necrosis factor-α (TNF-α) and leukotriene B4 (LTB4) in lavage fluid were detected via reverse transcription-quantitative polymerase chain reaction. The lung functions of patients in the two-time lavage group were significantly improved compared with that in the one-time lavage group (p<0.01). pH and PaO2 in two-time lavage group were higher than those in the one-time lavage group (p<0.01). Peripheral WBC, PCT and CRP levels in the two-time lavage group were lower than those in the one-time lavage group (p<0.05). The mRNA levels of IL-6, IL-8, TNF-α and LTB4 in lavage fluid in two-time lavage group were lower than those in one-time lavage group (p<0.01). IL-6, IL-8, TNF-α and LTB4 expression levels in lavage fluid in two-time lavage group were lower than those in one-time lavage group (p<0.01). In conclusion, the adjuvant therapy with bronchoalveolar lavage improves the therapeutic effect on COPD patients complicated with pneumonia, which can significantly reduce the expression levels of inflammatory factors, and facilitate the control of pulmonary infection and recovery of lung function.

Resveratrol Protects Against Nicotine-Induced Apoptosis by Enhancing Autophagy in BEAS-2B Lung Epithelial Cells

“…24 As the global population has continued to age, the incidence of COPD has also increased in recent years. 25 Therefore, the need to identify more potential therapeutic targets related to protecting against the harmful effects of cigarette smoking is urgent, as such knowledge will provide new avenues for the prevention and treatment of COPD.…”

Monitoring bronchoalveolar lavage with electrical impedance tomography: first experience in a patient with COVID-19

“…In particular, BAL has been reported to diagnose pathogenic infections of COVID-19 (Zhou et al 2020, Liu et al 2020. On the other hand, BAL could also be used to remove mucus, improve airway ventilation and reduce airway inflammation in chronic obstructive pulmonary disease (Zhao et al 2018) and pulmonary alveolar proteinosis (Smith et al 2019). However, there is a risk of regional airway collapse and atelectasis, which needs to be monitored.…”

Brochoscopic Airway Clearance Therapy vs. Conventional Sputum Aspiration: The Future of Flexible Brochoscopes in Intensive Care Units?

“…Currently, the Respiratory Endoscopy Committee of the Chinese Medical Association also recommended the appropriate application of flexible bronchoscopes in critically ill patients in the ICU [10]. However, the effectiveness of B-ACT in SP patients during IMV remains controversial over the years, knowing that B-ACT recommendations in currently available guidelines mainly rely on studies enrolling SP patients without undergoing IMV [11,12]. In addition, to the best of our knowledge, there are few studies reporting the optimal frequency of B-ACT and the target groups patients that benefit most from it in SP patients undergoing IMV, especially in the ICU.…”